Literature DB >> 10391763

Treating patients with severe sepsis.

T W Felbinger, U Suchner, A E Goetz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10391763

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Regulatory effect and mechanisms of carbon monoxide-releasing molecule II on hepatic energy metabolism in septic mice.

Authors:  Feng Liang; Jie Cao; Wei-Ting Qin; Xu Wang; Xue-Feng Qiu; Bing-Wei Sun
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

2.  Curcumin protects against lipopolysaccharide-induced vasoconstriction dysfunction via inhibition of thrombospondin-1 and transforming growth factor-β1.

Authors:  Wei Lu; Jian-Ping Jiang; Jue Hu; Jue Wang; Ming-Zhi Zheng
Journal:  Exp Ther Med       Date:  2014-12-03       Impact factor: 2.447

3.  YgiM may act as a trigger in the sepsis caused by Klebsiella pneumoniae through the membrane-associated ceRNA network.

Authors:  Mingxiao Han; Zhihao Chen; Ping He; Ziyuan Li; Qi Chen; Zelei Tong; Min Wang; Hong Du; Haifang Zhang
Journal:  Front Genet       Date:  2022-09-23       Impact factor: 4.772

4.  Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study.

Authors:  Lin Feng; Xin Zhou; Long-Xiang Su; Dan Feng; Yan-Hong Jia; Li-Xin Xie
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.